These findings suggest that FGF21 may be an early predictor of CIN and subsequent renal function decline, and provide novel evidence of FGF21′s involvement in non-diabetic kidney disease. This evidence concerns the gene FGF21 and cervical squamous intraepithelial neoplasia.